Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma (CATRIPCA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03871959
Recruitment Status : Recruiting
First Posted : March 12, 2019
Last Update Posted : May 10, 2021
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Debiopharm International SA
Information provided by (Responsible Party):
Centre Leon Berard

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 15, 2021
Estimated Study Completion Date : December 15, 2022